innat
immun
system
recogn
pathogenassoci
molecular
pattern
pamp
viral
bacteri
intrud
via
pattern
recognit
receptor
prr
includ
famili
tlr
consist
relat
transmembran
protein
play
central
role
initi
inflammatori
respons
includ
secret
cytokin
chemokin
mainli
express
cell
immun
monocyt
macrophag
dendrit
long
recogn
prr
sens
lipopolysaccharid
lp
compon
outer
membran
gramneg
bacteria
activ
lp
best
studi
ligand
multistep
process
initi
step
involv
lp
bind
protein
lbp
extract
lp
bacteri
membran
lpscontain
vesicl
transfer
coreceptor
cluster
differenti
exist
two
form
solubl
membranebound
form
abl
interact
lpsload
lbp
break
lp
aggreg
transfer
monomer
lp
hydrophob
pocket
myeloid
differenti
factor
part
complex
highaffin
bind
lp
lead
dimer
activ
complex
activ
result
recruit
intracellular
adaptor
protein
myeloid
differenti
primari
respons
andor
receptor
tir
domaincontain
adapterinduc
trif
ultim
result
express
secret
proinflammatori
mediat
also
shown
sensor
damageassoci
molecular
pattern
damp
includ
wide
varieti
molecul
releas
injur
die
tissu
well
molecul
activ
releas
respons
cellular
stress
intact
cell
addit
bacteri
pamp
cellular
damp
also
recogn
pamp
pathogen
includ
fungi
parasit
virus
complex
activ
damp
nonlp
pamp
vari
wide
structur
similar
lp
determin
resolv
structur
complex
critic
part
toward
dissect
mechan
activ
grow
list
virus
induc
inflammatori
respons
acut
infect
activ
known
viral
protein
includ
rsv
fusion
protein
f
ebov
glycoprotein
vesicular
stomat
viru
glycoprotein
vsv
g
dengu
viru
denv
nonstructur
protein
number
common
viral
activ
exampl
protein
membraneassoci
vsv
g
rsv
f
ebov
glycoprotein
classic
viral
glycoprotein
expos
surfac
viral
particl
mediat
fusion
host
cell
membran
hydrophob
fusion
peptid
fusion
domain
expos
consider
conform
chang
occur
plasma
membran
rsv
f
endosom
vsv
g
ebov
glycoprotein
denv
although
seemingli
dissimilar
surfac
glycoprotein
exist
multipl
form
includ
secret
membranebound
form
hydrophob
fusion
peptid
rsv
f
suggest
bind
deep
hydrophob
pocket
similarli
lp
mediat
activ
stimul
membranebound
ebov
glycoprotein
secret
cleav
form
shed
glycoprotein
retain
hydrophob
fusion
domain
differ
secret
version
ebov
lack
fusion
peptid
although
denv
lack
fusion
peptid
contain
expos
hydrophob
domain
mediat
membran
interact
could
play
role
activ
antagonist
suppress
lpsinduc
signal
competit
interact
lp
bacterium
rhodobact
sphaeroid
lpsr
eritoran
also
suppress
rsv
f
ebov
glycoprotein
denv
activ
suggest
similar
mechan
action
howev
remain
determin
larg
glycoprotein
interact
receptor
complex
way
hydrophob
region
would
access
interact
potenti
activ
signal
vsv
g
rsv
f
ebov
glycoprotein
denv
glycosyl
although
possibl
glycosyl
protein
mere
coincid
mani
membranebound
protein
glycosyl
rais
question
whether
glycosyl
gener
featur
requir
viral
activ
inde
lp
glycan
structur
play
essenti
role
regul
differ
step
activ
includ
increas
stabil
complex
via
direct
interact
lp
core
saccharid
viral
activ
glycosyl
ebov
glycoprotein
requir
activ
known
whether
also
case
viral
glycoprotein
unlik
virus
mention
iav
activ
specif
viral
protein
rather
induc
activ
host
damp
includ
highmobl
group
box
protein
oxid
phospholipid
accumul
respons
infect
also
glycoprotein
activ
bind
wherea
host
damp
might
play
central
role
acut
lung
injuri
detect
lung
patient
sever
iav
sarscov
infect
role
dampmedi
activ
viral
infect
remain
larg
unexplor
treatment
antagonist
consist
result
reduc
cytokin
chemokin
product
mitig
diseas
symptom
small
anim
model
iav
ebov
denv
infect
clearli
identifi
role
activ
pathogenesi
viral
diseas
lethal
infect
mice
ebov
iav
prevent
treatment
antagonist
highlight
therapeut
potenti
compound
pictur
becom
complic
howev
knockout
mice
use
mice
lack
either
similar
surviv
rate
even
sever
diseas
wildtyp
mice
infect
denv
ebov
sarscov
rsv
infect
knockout
mice
iav
result
varieti
outcom
possibl
due
variat
genet
background
mous
strain
use
differ
experiment
system
includ
analyz
time
point
altogeth
data
knockout
mice
suggest
protect
immun
respons
virus
might
requir
degre
activ
fig
role
activ
ebov
diseas
particularli
noteworthi
contrast
highli
pathogen
ebov
reston
viru
restv
member
ebolaviru
genu
believ
nonpathogen
human
lack
abil
significantli
stimul
provid
evid
activ
contribut
ebov
pathogen
nonhuman
primat
infect
ebov
stock
equal
titer
stock
higher
unit
pfu
ratio
associ
increas
diseas
sever
possibl
explan
observ
could
glycoprotein
expos
surfac
noninfecti
ebov
particl
activ
therebi
enhanc
damag
inflammatori
respons
final
shed
glycoprotein
detect
high
level
ebovinfect
guinea
pig
particularli
shortli
death
shed
glycoprotein
suffici
stimul
cytokin
respons
absenc
infect
suggest
noninfect
cell
stimul
shed
glycoprotein
might
contribut
complex
inflammatori
respons
ebov
diseas
given
high
mutat
rate
rna
virus
enabl
escap
challeng
host
respons
question
aris
whether
activ
benefici
product
viral
infect
one
potenti
benefit
activ
viral
infect
might
induc
specif
host
factor
promot
viral
replic
repress
antivir
activ
evid
activ
ebov
infect
increas
express
suppressor
cytokin
signal
shown
enhanc
viral
particl
releas
cell
surviv
factor
prevent
prematur
apoptot
cell
death
activ
infect
iav
rsv
denv
sarscov
activ
mediat
innat
immun
could
skew
adapt
immun
respons
manner
favor
viral
replic
specul
howev
addit
research
need
understand
effect
activ
viral
propag
conclus
activ
seem
play
nuanc
role
viral
infect
although
overstimul
lead
excess
inflammatori
respons
damag
host
certain
amount
activ
may
benefici
host
help
establish
protect
immun
respons
studi
wellknown
inhibitor
convincingli
show
dampen
excess
inflammatori
respons
mitig
diseas
promot
surviv
highlight
therapeut
potenti
inhibitor
viral
infect
work
need
dissect
mechan
larg
viral
glycoprotein
activ
sever
question
particular
interest
remain
glycan
structur
hydrophob
domain
viral
activ
requir
activ
could
lipid
modif
contribut
activ
factor
lead
uncontrol
cytokin
releas
versu
balanc
activ
confer
protect
immun
respons
consid
devast
inflamm
induc
virus
determin
virus
activ
may
critic
understand
pathogen
caus
sever
diseas
also
develop
effect
antivir
therapi
